Bausch + Lomb logo
Bausch + Lomb
BLCO | NYSE
Chart Builder DCF Calculator
$20.88
-$0.21 (-1.00%)
At close: Nov 16, 2026, 4:00 PM ET
$20.88
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:49 PM ET

Bausch + Lomb Company Profile

Company profile explained

Company Profile

Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options. This segment also provides essential contact lens care products, over-the-counter eye drops, and nutritional supplements aimed at alleviating common eye conditions like allergies, conjunctivitis, and dry eye. Through its Ophthalmic Pharmaceuticals segment, the company develops and markets both proprietary and generic prescription medications. These pharmaceuticals are utilized for post-operative recovery and the treatment of various ocular diseases, such as glaucoma, ocular hypertension, and retinal disorders. Additionally, it supplies therapeutic contact lenses. The Surgical segment is dedicated to providing advanced tools and technologies for surgical interventions related to cataracts, as well as vitreous and retinal conditions. Its offerings include intraocular lenses (IOLs) with their delivery systems, phacoemulsification equipment, and a range of other specialized surgical instruments and devices. Founded in 1853, Bausch + Lomb is headquartered in Vaughan, Canada.

Key Executives

Name Position
Brenton L. Saunders Chief Executive Officer & Director
A. Robert D. Bailey Executive Vice President & Chief Legal Officer
Osama A. Eldessouky Executive Vice President & Chief Financial Officer
Alan Waterhouse CPFA Executive Vice President and Chief Supply Chain & Operations Officer
Andrew Stewart President of Global Pharmaceuticals & International Consumer
Asli Gevgilili Executive Vice President & Chief Human Resources Officer
Crawford Chief Communications Officer
Frederick J. Munsch Senior Vice President, Controller & Chief Accounting Officer
George Gadkowski Vice President & Head of Investor Relations & Business Insights
John Ferris President of Consumer
Jonathon L. Kellerman Chief Compliance Officer
Luc Bonnefoy President of Surgical
Manisha A. Narasimhan Chief Corporate Development & Digital Officer
Yang Yang President of Vision Care
Yehia Hashad Executive Vice President of Research & Development and Chief Medical officer

Latest SEC Filings

Date Type Title
Oct 28, 2026 8-K Current Report
Oct 28, 2026 10-Q Quarterly Report
Oct 28, 2026 8-K Current Report
Oct 13, 2026 8-K Current Report
Aug 14, 2026 4 Filing
Aug 14, 2026 3 Filing
Aug 14, 2026 4 Filing
Aug 14, 2026 3 Filing
Aug 14, 2026 4 Filing
Aug 14, 2026 3 Filing
View All SEC Filings ➞
Bausch + Lomb
Bausch + Lomb logo
Country Canada
IPO Date May 6, 2022
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 13,000
CEO Thomas J. Appio

Contact Details

520 Applewood Crescent Vaughan, ON L4K 4B4 Canada

Stock Details

Ticker Symbol BLCO
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001860742
CUSIP Number 071705107
ISIN Number CA0717051076
SIC Code 3851

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.